ZLAB - Spark Newswire

1 minute read

Zai Lab Q1 EPS $(0.86) Beats $(1.20) Estimate, Sales $46.72M Beat $45.72M Estimate

May 10, 4:24 PM

Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(1.20) by 28.33 percent. This is a 67.42 percent increase over losses of $(2.64) per share from the same

ZLAB

20 minute read

Earnings Scheduled For May 10, 2022

By Benzinga Insights

May 10, 5:18 AM

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

ABCL

1 minute read

Earnings

Zai Lab’s Earnings Outlook

By Benzinga Insights

May 9, 2:09 PM

Zai Lab (NASDAQ:ZLAB) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Zai Lab will report an earnings per share (EPS) of $-1.20.

ZLAB

1 minute read

SVB Leerink Maintains Outperform on Zai Lab, Lowers Price Target to $101

By Benzinga Newsdesk

April 21, 11:15 AM

SVB Leerink analyst Jonathan Chang maintains Zai Lab (NASDAQ:ZLAB) with a Outperform and lowers the price target from $102 to $101.

ZLAB

5 minute read

Uncategorized

Cancer Drug Maker BeiGene Takes Action to Mitigate Delisting Risk

By The Bamboo Works

April 11, 11:34 AM

Key Takeaways: BeiGene has switched auditors for its New York listing to a U.S. company from a Chinese one in a move to comply with U.S. law The change could reduce the company’s threat of being forcibly delisted from the Nasdaq By Doug Young

BGNE

1 minute read

JP Morgan Maintains Overweight on Zai Lab, Lowers Price Target to $112

By Benzinga Newsdesk

April 4, 10:14 AM

JP Morgan analyst Anupam Rama maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $136 to $112.

ZLAB

1 minute read

Zai Lab’s Niraparib Shows 3X Longer PFS Compared to Placebo In Ovarian Cancer

By Vandana Singh

March 21, 9:54 AM

Zai Lab Limited (NASDAQ: ZLAB)

ZLAB

3 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

March 16, 1:38 PM

AGLE

4 minute read

61 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

March 16, 12:21 PM

Gainers

AGRI

4 minute read

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

By Shanthi Rexaline

March 13, 5:37 PM

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.

ACIU

Feed Symbols: ZLAB